Blog
RSS FeedPosted by Michael Wonder on 14 Sep 2016
CADTH update for patient groups
13 September 2016 - CADTH is inviting patient group comments and feedback on the proposed revisions to the patient input template ...
Posted by Michael Wonder on 14 Sep 2016
SMC introductory industry engagement event - September 2016
13 September 2016 - This event is designed to help pharmaceutical industry members who require an understanding of the processes for ...
Posted by Michael Wonder on 13 Sep 2016
CADTH calls for patient input on submission from Sanofi for sarilumab
13 September 2016 - CADTH is calling for patient input on Sanofi Genzyme's new interleukin 6 receptor antagonist. ...
Posted by Michael Wonder on 13 Sep 2016
Updated SMC guidance on comparator medicines with a patient access scheme
12 September 2016 - The SMC’s guidance to manufacturers about comparator medicines accepted for use on the basis of a confidential ...
Posted by Michael Wonder on 12 Sep 2016
Blood cancer drug approved for use on Scottish NHS
12 September 2016 - Scottish patients with a rare form of blood cancer have been granted access to a daily pill ...
Posted by Michael Wonder on 12 Sep 2016
SMC - September 2016 decisions
12 September 2016 - Three new medicines accepted for routine use by NHS Scotland. ...
Posted by Michael Wonder on 11 Sep 2016
CADTH calls for patient input on submission from Duchesnay for Mictoryl (propiverine hydrochloride)
9 February 2016 - CADTH is seeking patient input on a submission from Duchesnay for Mictoryl. ...
Posted by Michael Wonder on 09 Sep 2016
More options to be made available to treat hepatitis C
9 September 2016 - Another ‘potential curative’ drug for people with chronic hepatitis C will be made available on the NHS. ...
Posted by Michael Wonder on 09 Sep 2016
Confirmed prices for 2016 October cycle
9 September 2016 - Confirmed 1 October 2016 prices resulting from the 2016 October cycle of price disclosure have now been ...
Posted by Michael Wonder on 09 Sep 2016
Proposal relating to two HIV treatments (Tivicay and Kivexa)
9 September 2016 - PHARMAC is seeking feedback on a proposal to list a new treatment for HIV, dolutegravir (Tivicay) and ...
Posted by Michael Wonder on 08 Sep 2016
Coil is more effective than pill as emergency contraception, says NICE
8 September 2016 - NICE is calling for women to be told that the coil is more effective than the ‘morning ...
Posted by Michael Wonder on 08 Sep 2016
Access to Medicines Working Group communiques
8 September 2016 - The communiques from the February 2015, September 2015 and April 2016 meetings of the Access to Medicines ...
Posted by Michael Wonder on 07 Sep 2016
Eribulin in liposarcoma: added benefit not proven
1 September 2016 - Neither results from a study of direct comparison nor from an indirect comparison were suitable. ...
Posted by Michael Wonder on 07 Sep 2016
IQWiG Autumn Symposium 2016: programme is now online
6 September 2016 - More light than shadow? Beneficial and hindering factors for successful clinical studies. ...
Posted by Michael Wonder on 06 Sep 2016
NICE rejects Roche’s melanoma combination
6 September 2016 - Patients in England and Wales with melanoma will not be getting routine access to Roche's Cotellic/Zelboraf combination ...